Drugs / Guli capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02484508 | Mar 2015 → Mar 2016 | osteoarthritis, knee | Guizhou Bailing Group Pharmaceutical Co Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guli capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02484508 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Guli capsule, an approved Chinese patent drug” NCT02484508 ↗ |